anmelden
BX Swiss TOP 30 CHF
1.508,52
PKT
-1,02
PKT
-0,07
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.11.12 | Nestlé kaufen | Hamburger Sparkasse AG (Haspa) | |
| 27.11.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 26.11.12 | Straumann hold | Vontobel Research | |
| 26.11.12 | Lonza hold | Vontobel Research | |
| 26.11.12 | Swiss Re neutral | Sarasin Research | |
| 26.11.12 | UBS neutral | Macquarie Research | |
| 26.11.12 | Swiss Re buy | Vontobel Research | |
| 26.11.12 | Straumann neutral | Sarasin Research | |
| 26.11.12 | Richemont buy | Sarasin Research | |
| 23.11.12 | Sonova kaufen | Fuchsbriefe | |
| 23.11.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.11.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 22.11.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 22.11.12 | Holcim buy | UBS AG | |
| 22.11.12 | Holcim buy | UBS AG | |
| 22.11.12 | Swiss Life buy | UBS AG | |
| 22.11.12 | Holcim hold | Vontobel Research | |
| 21.11.12 | UBS overweight | Morgan Stanley | |
| 21.11.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 21.11.12 | Novartis reduce | Vontobel Research | |
| 20.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 20.11.12 | UBS neutral | Exane-BNP Paribas SA | |
| 20.11.12 | UBS outperform | Exane-BNP Paribas SA | |
| 20.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 20.11.12 | Novartis buy | Sarasin Research | |
| 20.11.12 | UBS neutral | Sarasin Research | |
| 20.11.12 | UBS hold | Vontobel Research | |
| 20.11.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 19.11.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 19.11.12 | UBS buy | Sarasin Research | |
| 19.11.12 | Zurich Insurance halten | Independent Research GmbH | |
| 16.11.12 | Zurich Insurance neutral | HSBC | |
| 16.11.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 16.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 16.11.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 16.11.12 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
| 16.11.12 | Zurich Insurance buy | Nomura | |
| 16.11.12 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 16.11.12 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 16.11.12 | Zurich Insurance hold | Vontobel Research |
